TRIP
47
3
WEC
53
-2
GT
62
6
BF.B
33
2
INTC
33
-2
EMN
60
4
AON
54
2
MSFT
50
3
PEP
48
6
WU
32
2
SE
61
-4
AA
48
-12
PG
56
5
CINF
53
2
UPS
60
9
BBY
46
10
HAS
33
3
VNO
60
10
HRB
57
5
SO
53
-4
TRIP
47
3
WEC
53
-2
GT
62
6
BF.B
33
2
INTC
33
-2
EMN
60
4
AON
54
2
MSFT
50
3
PEP
48
6
WU
32
2
SE
61
-4
AA
48
-12
PG
56
5
CINF
53
2
UPS
60
9
BBY
46
10
HAS
33
3
VNO
60
10
HRB
57
5
SO
53
-4
Financhill
Back

ResMed 10K Form

Sell
50

RMD
ResMed

Last Price:
243.68
Seasonality Move:
7.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-10-27 10Q RMD/ResMed Quarterly
2023-04-28 10Q RMD/ResMed Quarterly
2023-01-27 10Q RMD/ResMed Quarterly
2022-10-28 10Q RMD/ResMed Quarterly
2022-04-29 10Q RMD/ResMed Quarterly
2022-01-28 10Q RMD/ResMed Quarterly

Receive RMD News And Ratings

See the #1 stock for the next 7 days that we like better than RMD

RMD Financial Statistics

Sales & Book Value

Annual Sales: $4.69B
Cash Flow: $305.93M
Price / Cash Flow: 26.7
Annual Sales: $35.39
Price / Book: 6.89

Profitability

EPS (TTM): 7.55000
Net Income (TTM): $1.11B
Gross Margin: $2.66B
Return on Equity: 23.76%
Return on Assets: 16.1%

ResMed Earnings Forecast

Key ResMed Financial Ratios

  • The Gross Profit Margin over the past 32 years for RMD is 56.67%.
  • The Selling, General & Administrative Expenses for RMD have been equal to 19.57% of Gross Profit Margin.
  • The Research & Development expenses have been 6.56% of Revenue.
  • The Interest Expense is 4.48% of Operating Income.
  • The Net Earning history of RMD is 21.79% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 24 years.

ResMed Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: RMD
CUSIP: 761152
Website: resmed.com

Debt

Debt-to-Equity Ratio: 0.13
Current Ratio: 2.92
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 35.23
Forward P/E Ratio: 23.71

RMD Technical Analysis vs Fundamental Analysis

Sell
50
ResMed (RMD) is a Sell

Is ResMed a Buy or a Sell?

  • ResMed stock is rated a Sell
    The current ResMed [RMD] share price is $243.78. The Score for RMD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.